Machine learning-based prediction of mortality after heart transplantation in adults with congenital heart disease: A

Polydoros N Kampaktsis1, Athanasios Siouras2, Ilias P Doulamis3

  • 1Division of Cardiology, Columbia University Irving Medical Center, New York, New York, USA.

Clinical Transplantation
|October 31, 2022
PubMed

Insights

Machine learning accurately predicts mortality after heart transplantation in adults with congenital heart disease. This tool aids in personalized risk assessment for better patient outcomes.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Transplantation Science

Background:

  • Machine learning (ML) is increasingly utilized in cardiology for outcome prediction and clinical decision support.
  • Adults with congenital heart disease (ACHD) undergoing heart transplantation (HT) represent a unique population with specific post-transplant risks.
  • Developing accurate predictive models for mortality in this cohort is crucial for improving patient management.

Purpose of the Study:

  • To develop and validate a machine learning model for predicting mortality in adults with congenital heart disease following heart transplantation.
  • To identify key predictors of mortality in this specific patient population.
  • To enable individualized mortality risk assessment.

Main Methods:

  • Utilized the United Network for Organ Sharing (UNOS) database (2000-2020) for adult patients with ACHD undergoing isolated HT.
  • Split the cohort into derivation (70%) and validation (30%) datasets to train and test a CatBoost ML model.
  • Employed SHapley Additive exPlanations (SHAP) for feature selection and explainability analysis, assessing recipient, donor, procedural, and post-transplant factors.

Main Results:

  • The study included 1033 recipients; 19.9% experienced mortality within 1 year post-HT.
  • A 1-year ML model achieved an Area Under the Curve (AUC) of 0.80 and 75.2% predictive accuracy; a 3-year model had an AUC of 0.69 and 74.2% accuracy.
  • SHAP analysis identified post-HT hemodialysis, estimated glomerular filtration rate, age, and ischemic time as significant predictors of 1-year mortality.

Conclusions:

  • Machine learning models demonstrate satisfactory predictive accuracy for mortality after heart transplantation in ACHD patients.
  • The developed ML model facilitates individualized mortality risk assessment, aiding clinical decision-making.
  • These findings highlight the potential of ML to enhance care for ACHD patients post-heart transplant.
Abstract